Citi Boosts Eli Lilly with Buy Rating, Eyes Growth
Citi resumes Eli Lilly coverage with Buy rating, driven by optimistic tirzepatide forecasts for diabetes and obesity treatments.
- Latest
- Trending
Citi resumes Eli Lilly coverage with Buy rating, driven by optimistic tirzepatide forecasts for diabetes and obesity treatments.
Roto VR Explorer chair matches head movements to reduce VR nausea, offering an immersive experience at an affordable price.
AbCellera Biologics Inc. progresses with their TCE platform and strategic partnerships, aiming for CTA submissions in Q2 2025.
Eli Lilly's Zepbound reduces sleep apnea by up to 52% in trials, showing promise beyond weight loss. FDA approval for ...
Explore if VR headsets harm eyesight and learn tips to combat digital eye strain and VR sickness. Understand the benefits ...
A groundbreaking study by Stanford University reveals how virtual reality technology is improving the emotional well-being and social interactions of ...
Apple's release of the Vision Pro VR headset opens up new possibilities for immersive experiences, but concerns about inappropriate use ...
Motion sickness in virtual reality (VR) remains a significant challenge, but companies like Apple are working to minimize discomfort. With ...
Users of the Apple Vision Pro are reporting headaches, eye strain, and motion sickness, leading to widespread dissatisfaction and potential ...
A recent study warns that prolonged use of Apple's Vision Pro headset may affect cognitive functions, causing spatial navigation difficulties ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.